Pacira Biosciences, Inc. (PCRX)
21.74
-1.12
(-4.90%)
USD |
NASDAQ |
Mar 06, 12:28
Pacira Biosciences EPS Diluted (Quarterly) : 0.0381 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| CorMedix, Inc. | 0.00 |
| Krystal Biotech, Inc. | 1.699 |
| Arcutis Biotherapeutics, Inc. | 0.1282 |
| ADMA Biologics, Inc. | 0.2025 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.637M |
| Revenue (Quarterly) | 196.87M |
| Total Expenses (Quarterly) | 195.24M |
| Enterprise Value | 1.105B |
| Gross Profit Margin (Quarterly) | 72.26% |
| Profit Margin (Quarterly) | 0.83% |
| Earnings Yield | 0.72% |
| Operating Earnings Yield | 3.45% |
| Normalized Earnings Yield | 1.822 |